Brand-name semaglutide escalation (Wegovy schedule) The diabetes-specific schedule (Ozempic) follows the same initial steps but caps at 2.0 mg weekly
In conclusion, semaglutide is a remarkable medication for the treatment for type 2 diabetes, weight loss, cardiovascular risk reduction, renal protection, and potential neuroprotective effects
While Ozempic only titrates to 2mg of Semaglutide, it's sister brand, Wegovy, is licensed to be used for weight loss all the way to 2.4mg
For example, a provider might prescribe 0.01mg per kilogram of body weight for the starting dose
Because stopping semaglutide typically leads to some degree of weight regain , many people continue treatment to maintain their results and protect against weight-related health risks